HemaSphere
(Oct 2022)
P032: Circulating immune biomarkers in classical Hodgkin lymphoma in relation to tumor burden and response to treatment.
- Tom A. Mulder,
- Maria L. Andersson,
- Lucia Peña-Pérez,
- Kia Heimersson,
- Ioanna Xagoraris,
- Björn E. Wahlin,
- Robert Månsson,
- Lotta Hansson,
- Georgios Z. Rassidakis,
- Marzia Palma
Affiliations
- Tom A. Mulder
- 1 Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- Maria L. Andersson
- 1 Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- Lucia Peña-Pérez
- 3 Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Kia Heimersson
- 1 Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- Ioanna Xagoraris
- 1 Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- Björn E. Wahlin
- 5 Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
- Robert Månsson
- 3 Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Lotta Hansson
- 1 Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- Georgios Z. Rassidakis
- 1 Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- Marzia Palma
- 1 Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- DOI
-
https://doi.org/10.1097/01.HS9.0000890696.02714.07
- Journal volume & issue
-
Vol. 6
pp.
15
– 16
WeChat QR code